Physiochemical characterization and release rate studies of solid dispersions of Ketoconazole with Pluronic F127 and PVP K-30

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 4, 2011, Pages 685-694

  Kumara, Pankaj ^a   Mohanb, Chander ^b   Uma Shankara, Mara Kanam Srinivasan ^a   Gulatia, Monica ^a  

^a LOVELY PROFESSIONAL UNIVERSITY   (India)

^b Rayat College of Pharmacy   (India)

Author keywords

Ketoconazole; Melt fusion; Pluronic F127; PVP K 30; Solid dispersion; Solvent evaporation

Indexed keywords

KETOCONAZOLE; POLOXAMER; POVIDONE DERIVATIVE; POVIDONE K30; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; THERMODYNAMICS; X RAY POWDER DIFFRACTION;

EID: 84859531522     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Levine HB. Ketoconazole in the management of fungal disease. Adis Press, New York (1982).
2. Gallia E, Nicolaides E, Horter D, Lobenberg R, Reppas C and Dressman JB. Evaluation of various dissolution media for redirecting in-vivo performance of class I and II drugs. Pharm. Res. (1998) 15: 698-705.
3. Krishnamoorthy V, Nagalingam A, Ranjan Prasad VP, Parameshwaran S, George N and Kaliyan P. Characterization of Olanzapine-solid dispersions. Iranian J. Pharm. Res. (2011) 10: 13-24.
4. Kai T, Akiyama Y, Nomura S and Sato M. Oral absorption improvement of poorly soluble drug using solid dispersion technique. Chem. Pharm. Bull. (1996) 44: 568-71.
5. Dehghan MH and Jafar M. Improving Dissolution of meloxicam using solid dispersions. Iranian J. Pharm. Res. (2006) 5: 231-238.
6. Chiou WL and Riegelman SJ. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. (1971) 60: 1281-1302.
7. Ford JL. The current status of solid dispersions. Pharm. Acta Helv. (1986) 61: 69-88.
8. Vasconcelos T, Sarmento B and Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water-soluble drugs. Drug Discovery Today (2007) 12: 1068-75.
9. Tanaka N, Imai K, Okimoto K, Ueda S and Tokunaga Y. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In-vivo evaluation. J. Contr. Rel. (2006) 112: 51-6.
10. Dehghan MH and Jafar M. Improving Dissolution of Meloxicam Using Solid Dispersions. Iranian J. Pharm. Res. (2006) 5: 231-238.
11. Vilhelmsen T, Eliasen H and Torben Schæfer T. Effect of a melt agglomeration process on agglomerates containing solid dispersions. Int. J. Pharm. (2005) 303: 132-42.
12. Urbanetz NA. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur. J. Pharm. Sci. (2006) 28: 67-76.
13. Damian F, Blaton N, Naesens L, Balzarini J and Kinget R. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and gelucire 44/14. Eur. J. Pharm. Sci. (2000) 10: 311-22.
14. Karata A, Yüksel N and Baykara T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Il Farmaco. (2005) 60: 777-82.
15. Morris KR, Knipp GT and Serajuddin ATM. Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle. J. Pharm. Sci. (1992) 81: 1185-88.
16. Alden M, Tegenfeldt J and Saers ES. Structures formed by interactions in solid dispersions of the system polyethylene glycol-griseofulvin with charged and noncharged surfactants added. Int. J. Pharm. (1993) 94: 31-8.
17. Sheen PC, Khetarpal VK, Cariola CM and Rowlings CE. Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int. J. Pharm. (1995) 118: 221-27.
18. Owusu-Ababio G, Ebube NK, Reams R and Habib M. Comparative dissolution studies for mefenamic acidpolyethylene glycol solid dispersion systems and tablets. Pharm. Dev. Technol. (1998) 3: 405-12.
19. Joshi HN, Tejwani RW, Davidovich M, Sahasrabudhe VP and Jemal M. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm. (2004) 269: 251-58.
20. van Drooge DJ. Inulin Glass Dispersions for Fast Dissolution, Stabilization and Formulation of Lipophilic Drugs. [Dissertattion] Dutch University of Groningen, the Netherlands (2006).
21. van den Mooter G, Weuts I, Ridder TD and Blaton N. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int. J. Pharm. (2006) 316: 1-6.
22. Li FQ, Hu JH, Deng JX, Su H, Xu S and Liu JY. In-vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int. J. Pharm. (2006) 324: 152-57.
23. Majerik V, Tejwani RW, Davidovich M, Sahasrabudhe VP and Jemal M. Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. J. Supercrit. Fluids (2007) 40: 101-10.
24. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. (2006) 29: 278-87.
25. Higuchi T and Connors KA. Phase solubility techniques. Adv. Anal. Chem. Instrum. (1965) 4: 117-12.
26. van Drooge DJ, Hinrichs WLJ, Visser MR and Frijlink HW. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapor sorption techniques. Int. J. Pharm. (2006) 310: 220-29.
27. th ed., Royal Pharmaceutical Society of Great Britain, London (2004) 508-13.
28. Sekiguchi K and Obi N. Studies on absorption of eutectic mixture. II. Absorption of fused conglomerates of chloramphenicol and urea in rabbits. Chem. Pharm. Bull. (1964) 12: 134-44.
29. Pokharkar VB, Mandpe LP, Padamwar MN, Ambike AA and Mahadik KR. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol. (2006) 167: 20-5.
30. Chengsheng L and Kashappa HD. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Dev. Ind. Pharm. (2005) 1: 1-10.
31. Patel RP, Patel DJ, Bhimani DB and Patel JK. Physicochemical characterization and dissolution study of solid dispersions of furosemide with polyethylene glycol 6000 and polyvinylpyrrolidone K-30. Diss. Tech. (2008) 17-25.
32. Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. (2002) 231: 131-44.
33. Hancock BC and Zografi G. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm. Res. (1994) 11: 471-77.
34. Bugay DE. Characterization of the solid-state: spectroscopic techniques. Adv. Drug Deliv. Rev. (2001) 48: 43-65.
35. Silverstein RM, Bassler GC and Morril TC. Spectrometric Identification of Organic Compounds. Wiley, New York (1991) 91-131.